Literature DB >> 20016450

Magnetic resonance imaging and spectroscopy methods for molecular imaging.

G Vande Velde1, V Baekelandt, T Dresselaers, U Himmelreich.   

Abstract

Magnetic resonance imaging (MRI), one of the most powerful imaging modalities available for clinical diagnosis, has contributed significantly to phenotyping of transgenic organisms and to cellular imaging and is now gaining importance in the field of molecular imaging. Its advantage is the ability to provide in vivo information with high resolution and good soft tissue contrast as compared to established other molecular imaging methods. MRI can non-invasively report on cell localisation and migration with detailed anatomical background information, which is of great interest in cellular therapies. Recent technological advances and contrast generation strategies aim to bring MRI beyond cellular imaging to the detection of functional changes in vivo. MR based monitoring of molecular processes, requires the development of contrast agents and targeting methods as well as improvements in the methods sensitivity. Here, an overview is provided on advanced MR technologies and contrast generation strategies for this purpose. This includes MRI and MR spectroscopic methods for molecular imaging and various approaches for targeted and responsive contrast generation to visualize functional changes of particular cells. A description of different methods is provided, as well as the potentials and challenges of MR techniques for the visualization of molecular processes in vivo.

Mesh:

Substances:

Year:  2009        PMID: 20016450

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  10 in total

Review 1.  Taking a deep look: modern microscopy technologies to optimize the design and functionality of biocompatible scaffolds for tissue engineering in regenerative medicine.

Authors:  M Vielreicher; S Schürmann; R Detsch; M A Schmidt; A Buttgereit; A Boccaccini; O Friedrich
Journal:  J R Soc Interface       Date:  2013-07-17       Impact factor: 4.118

Review 2.  The evolution of imaging in cancer: current state and future challenges.

Authors:  Luke J Higgins; Martin G Pomper
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

Review 3.  Activatable T₁ and T₂ magnetic resonance imaging contrast agents.

Authors:  Chuqiao Tu; Elizabeth A Osborne; Angelique Y Louie
Journal:  Ann Biomed Eng       Date:  2011-02-18       Impact factor: 3.934

4.  Tracking of Labelled Stem Cells Using Molecular MR Imaging in a Mouse Burn Model in Vivo as an Approach to Regenerative Medicine.

Authors:  Zeba Qadri; Valeria Righi; Shasha Li; A Aria Tzika
Journal:  Adv J Mol Imaging       Date:  2021-01

5.  Magnetic resonance reporter gene imaging.

Authors:  Sheen-Woo Lee; Sang-Hoon Lee; Sandip Biswal
Journal:  Theranostics       Date:  2012-04-12       Impact factor: 11.556

Review 6.  Principles and basic concepts of molecular imaging.

Authors:  Nicolas Grenier; Peter Brader
Journal:  Pediatr Radiol       Date:  2010-09-29

Review 7.  Ferritin family proteins and their use in bionanotechnology.

Authors:  Didi He; Jon Marles-Wright
Journal:  N Biotechnol       Date:  2015-01-05       Impact factor: 5.079

8.  Molecular imaging: from bench to clinic.

Authors:  Yì-Xiáng J Wáng; Yongdoo Choi; Zhiyi Chen; Sophie Laurent; Summer L Gibbs
Journal:  Biomed Res Int       Date:  2014-12-29       Impact factor: 3.411

9.  Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI.

Authors:  Raquel Martínez-González; Joan Estelrich; Maria Antònia Busquets
Journal:  Int J Mol Sci       Date:  2016-07-27       Impact factor: 5.923

Review 10.  Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma.

Authors:  Senthilkumar Kalimuthu; Ju Hye Jeong; Ji Min Oh; Byeong-Cheol Ahn
Journal:  Int J Mol Sci       Date:  2017-07-27       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.